
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1212px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_1{left:79px;top:98px;word-spacing:4.7px;}
#t2_1{left:79px;top:116px;letter-spacing:-0.3px;word-spacing:-4.6px;}
#t3_1{left:79px;top:133px;letter-spacing:-0.2px;word-spacing:15.1px;}
#t4_1{left:79px;top:151px;letter-spacing:-0.3px;word-spacing:2.9px;}
#t5_1{left:79px;top:168px;}
#t6_1{left:96px;top:168px;letter-spacing:-0.2px;word-spacing:1.2px;}
#t7_1{left:352px;top:168px;}
#t8_1{left:362px;top:168px;letter-spacing:-0.2px;word-spacing:1px;}
#t9_1{left:79px;top:186px;letter-spacing:-0.3px;word-spacing:-0.8px;}
#ta_1{left:79px;top:204px;letter-spacing:-0.2px;word-spacing:11.9px;}
#tb_1{left:79px;top:221px;letter-spacing:-0.3px;word-spacing:2.4px;}
#tc_1{left:412px;top:221px;letter-spacing:-0.4px;}
#td_1{left:429px;top:221px;}
#te_1{left:98px;top:239px;word-spacing:31.2px;}
#tf_1{left:79px;top:257px;word-spacing:20.9px;}
#tg_1{left:79px;top:274px;word-spacing:5.3px;}
#th_1{left:79px;top:292px;word-spacing:18px;}
#ti_1{left:79px;top:310px;word-spacing:7.7px;}
#tj_1{left:79px;top:327px;word-spacing:2.9px;}
#tk_1{left:79px;top:345px;word-spacing:-1.9px;}
#tl_1{left:150px;top:345px;}
#tm_1{left:167px;top:345px;word-spacing:-1.9px;}
#tn_1{left:79px;top:363px;word-spacing:2.7px;}
#to_1{left:79px;top:380px;word-spacing:5px;}
#tp_1{left:79px;top:398px;word-spacing:4.2px;}
#tq_1{left:172px;top:398px;}
#tr_1{left:189px;top:398px;}
#ts_1{left:98px;top:416px;word-spacing:25.9px;}
#tt_1{left:79px;top:433px;word-spacing:8.3px;}
#tu_1{left:79px;top:451px;word-spacing:14.2px;}
#tv_1{left:79px;top:469px;word-spacing:-1.4px;}
#tw_1{left:79px;top:486px;word-spacing:6.8px;}
#tx_1{left:79px;top:504px;word-spacing:21.5px;}
#ty_1{left:79px;top:522px;word-spacing:3.8px;}
#tz_1{left:79px;top:539px;word-spacing:15.7px;}
#t10_1{left:79px;top:557px;word-spacing:7.5px;}
#t11_1{left:79px;top:575px;word-spacing:0.7px;}
#t12_1{left:79px;top:592px;word-spacing:1.2px;}
#t13_1{left:79px;top:610px;word-spacing:13.4px;}
#t14_1{left:79px;top:627px;word-spacing:9.9px;}
#t15_1{left:79px;top:645px;word-spacing:4.4px;}
#t16_1{left:490px;top:98px;letter-spacing:-0.2px;word-spacing:2.6px;}
#t17_1{left:472px;top:116px;letter-spacing:-0.3px;word-spacing:-2.4px;}
#t18_1{left:472px;top:133px;letter-spacing:-0.2px;word-spacing:17.5px;}
#t19_1{left:472px;top:151px;letter-spacing:-0.3px;word-spacing:17.9px;}
#t1a_1{left:684px;top:151px;letter-spacing:-0.4px;}
#t1b_1{left:701px;top:151px;letter-spacing:-0.2px;word-spacing:18px;}
#t1c_1{left:472px;top:168px;letter-spacing:-0.3px;word-spacing:-0.9px;}
#t1d_1{left:472px;top:186px;letter-spacing:-0.3px;}
#t1e_1{left:472px;top:214px;word-spacing:3.7px;}
#t1f_1{left:580px;top:214px;word-spacing:3.7px;}
#t1g_1{left:472px;top:244px;}
#t1h_1{left:478px;top:273px;}
#t1i_1{left:498px;top:273px;word-spacing:-0.3px;}
#t1j_1{left:498px;top:289px;word-spacing:3.7px;}
#t1k_1{left:478px;top:305px;}
#t1l_1{left:498px;top:305px;letter-spacing:-0.2px;word-spacing:1.1px;}
#t1m_1{left:498px;top:322px;letter-spacing:-0.2px;word-spacing:-2.5px;}
#t1n_1{left:498px;top:338px;letter-spacing:-0.3px;word-spacing:1.8px;}
#t1o_1{left:478px;top:354px;}
#t1p_1{left:498px;top:354px;word-spacing:10.5px;}
#t1q_1{left:498px;top:370px;word-spacing:7.4px;}
#t1r_1{left:498px;top:386px;word-spacing:3.7px;}
#t1s_1{left:478px;top:402px;word-spacing:1px;}
#t1t_1{left:498px;top:418px;word-spacing:7.1px;}
#t1u_1{left:498px;top:435px;word-spacing:8.4px;}
#t1v_1{left:749px;top:435px;}
#t1w_1{left:498px;top:451px;}
#t1x_1{left:478px;top:467px;}
#t1y_1{left:498px;top:467px;word-spacing:2.5px;}
#t1z_1{left:498px;top:483px;word-spacing:14.5px;}
#t20_1{left:498px;top:499px;}
#t21_1{left:713px;top:534px;word-spacing:3.7px;}
#t22_1{left:833px;top:533px;}
#t23_1{left:521px;top:550px;word-spacing:3.8px;}
#t24_1{left:515px;top:581px;word-spacing:3.8px;}
#t25_1{left:653px;top:598px;word-spacing:3.8px;}
#t26_1{left:514px;top:614px;word-spacing:3.6px;}
#t27_1{left:598px;top:614px;}
#t28_1{left:835px;top:614px;}
#t29_1{left:472px;top:647px;}
#t2a_1{left:79px;top:703px;word-spacing:13.5px;}
#t2b_1{left:79px;top:719px;word-spacing:4.4px;}
#t2c_1{left:79px;top:737px;word-spacing:4.3px;}
#t2d_1{left:79px;top:769px;word-spacing:4.5px;}
#t2e_1{left:79px;top:804px;word-spacing:4.6px;}
#t2f_1{left:79px;top:822px;letter-spacing:-0.2px;word-spacing:11.7px;}
#t2g_1{left:79px;top:839px;letter-spacing:-0.3px;word-spacing:4.7px;}
#t2h_1{left:79px;top:857px;letter-spacing:-0.3px;word-spacing:21.6px;}
#t2i_1{left:79px;top:875px;letter-spacing:-0.2px;word-spacing:10.9px;}
#t2j_1{left:79px;top:892px;letter-spacing:-0.3px;word-spacing:1.9px;}
#t2k_1{left:79px;top:910px;letter-spacing:-0.2px;word-spacing:3px;}
#t2l_1{left:79px;top:928px;letter-spacing:-0.2px;word-spacing:9.5px;}
#t2m_1{left:79px;top:945px;letter-spacing:-0.3px;word-spacing:-1.6px;}
#t2n_1{left:79px;top:963px;letter-spacing:-0.2px;word-spacing:4px;}
#t2o_1{left:79px;top:981px;letter-spacing:-0.3px;word-spacing:-3.6px;}
#t2p_1{left:79px;top:998px;letter-spacing:-0.2px;word-spacing:2.2px;}
#t2q_1{left:98px;top:1016px;letter-spacing:-0.2px;word-spacing:0.8px;}
#t2r_1{left:79px;top:1033px;letter-spacing:-0.2px;word-spacing:0.1px;}
#t2s_1{left:79px;top:1051px;letter-spacing:-0.2px;word-spacing:11.3px;}
#t2t_1{left:79px;top:1069px;letter-spacing:-0.3px;word-spacing:-0.2px;}
#t2u_1{left:79px;top:1086px;letter-spacing:-0.3px;word-spacing:17.2px;}
#t2v_1{left:79px;top:1104px;letter-spacing:-0.3px;word-spacing:3.1px;}
#t2w_1{left:79px;top:1122px;letter-spacing:-0.2px;word-spacing:-4.5px;}
#t2x_1{left:277px;top:1122px;}
#t2y_1{left:287px;top:1122px;letter-spacing:-0.1px;word-spacing:-4.7px;}
#t2z_1{left:472px;top:703px;letter-spacing:-0.3px;word-spacing:3.4px;}
#t30_1{left:472px;top:720px;letter-spacing:-0.3px;word-spacing:22.4px;}
#t31_1{left:472px;top:738px;letter-spacing:-0.2px;word-spacing:2.8px;}
#t32_1{left:472px;top:756px;letter-spacing:-0.3px;word-spacing:-1.1px;}
#t33_1{left:472px;top:773px;letter-spacing:-0.3px;word-spacing:2.3px;}
#t34_1{left:472px;top:803px;word-spacing:4.6px;}
#t35_1{left:472px;top:821px;word-spacing:-2.2px;}
#t36_1{left:472px;top:839px;word-spacing:8.7px;}
#t37_1{left:472px;top:856px;word-spacing:5.1px;}
#t38_1{left:472px;top:874px;word-spacing:2.5px;}
#t39_1{left:472px;top:892px;word-spacing:17.5px;}
#t3a_1{left:472px;top:909px;}
#t3b_1{left:519px;top:909px;}
#t3c_1{left:539px;top:909px;word-spacing:0.2px;}
#t3d_1{left:817px;top:909px;}
#t3e_1{left:834px;top:909px;}
#t3f_1{left:490px;top:927px;letter-spacing:-0.4px;word-spacing:0.3px;}
#t3g_1{left:472px;top:945px;letter-spacing:-0.4px;word-spacing:-4.1px;}
#t3h_1{left:472px;top:962px;letter-spacing:-0.4px;word-spacing:-2.1px;}
#t3i_1{left:472px;top:980px;letter-spacing:-0.2px;word-spacing:-2px;}
#t3j_1{left:504px;top:980px;letter-spacing:-0.5px;}
#t3k_1{left:521px;top:980px;letter-spacing:-0.4px;word-spacing:-1.1px;}
#t3l_1{left:472px;top:998px;letter-spacing:-0.1px;word-spacing:-5px;}
#t3m_1{left:472px;top:1015px;letter-spacing:-0.4px;word-spacing:9.2px;}
#t3n_1{left:472px;top:1033px;letter-spacing:-0.4px;word-spacing:-0.5px;}
#t3o_1{left:472px;top:1051px;letter-spacing:-0.4px;word-spacing:4.1px;}
#t3p_1{left:472px;top:1068px;letter-spacing:-0.3px;word-spacing:-1.8px;}
#t3q_1{left:472px;top:1086px;letter-spacing:-0.4px;word-spacing:18.5px;}
#t3r_1{left:552px;top:1086px;letter-spacing:-0.5px;}
#t3s_1{left:569px;top:1086px;letter-spacing:-0.3px;word-spacing:18.2px;}
#t3t_1{left:472px;top:1104px;letter-spacing:-0.4px;word-spacing:3.1px;}
#t3u_1{left:472px;top:1121px;letter-spacing:-0.4px;word-spacing:2.4px;}
#t3v_1{left:331px;top:50px;letter-spacing:6.6px;word-spacing:4.4px;}
#t3w_1{left:815px;top:47px;}

.s4_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: JLJMNH-AdvP4C4E511;
	color: rgb(0,0,0);
}

.s9_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JLJMNG-AdvP4DF60F1;
	color: rgb(0,0,0);
}

.s5_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JLJMOI-AdvP4DF6121;
	color: rgb(0,0,0);
}

.s11_1{
	FONT-SIZE: 39px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s6_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s10_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: JLJMMG-AdvP4C4E741;
	color: rgb(0,0,0);
}

.s12_1{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: JLJMLE-AdvP4DF6141;
	color: rgb(0,0,0);
}

.s3_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(0,104,156);
}

.s7_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(35,31,32);
}

.s1_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: JLJMLE-AdvP4DF6141;
	color: rgb(0,0,0);
}

.s2_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s8_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JLJMLF-AdvP4DF60E1;
	color: rgb(0,104,156);
}

.v1_1{
	-webkit-transform: scale(0.259, 0.25);
	-ms-transform: scale(0.259, 0.25);
	-moz-transform: scale(0.259, 0.25);
	-o-transform: scale(0.259, 0.25);
}

#form1_1{	border-style:none;	z-index:2;	position: absolute;	left:552px;	top:1088px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_2{	border-style:none;	z-index:2;	position: absolute;	left:411px;	top:223px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_3{	border-style:none;	z-index:2;	position: absolute;	left:148px;	top:347px;	width:20px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_4{	border-style:none;	z-index:2;	position: absolute;	left:683px;	top:153px;	width:20px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_5{	border-style:none;	z-index:2;	position: absolute;	left:78px;	top:170px;	width:19px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_6{	border-style:none;	z-index:2;	position: absolute;	left:518px;	top:911px;	width:19px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_7{	border-style:none;	z-index:2;	position: absolute;	left:171px;	top:399px;	width:19px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_8{	border-style:none;	z-index:2;	position: absolute;	left:503px;	top:981px;	width:20px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_9{	border-style:none;	z-index:2;	position: absolute;	left:816px;	top:911px;	width:20px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_10{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:500px;	width:87px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_11{	border-style:none;	z-index:2;	position: absolute;	left:749px;	top:436px;	width:89px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_12{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:452px;	width:153px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_13{	border-style:none;	z-index:2;	position: absolute;	left:598px;	top:616px;	width:239px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_14{	border-style:none;	z-index:2;	position: absolute;	left:471px;	top:648px;	width:242px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_15{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:387px;	width:272px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_16{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:307px;	width:341px;	height:11px;	text-align:left;	background: transparent;	font:normal 7px Arial, Helvetica, sans-serif;}
#form1_17{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:339px;	width:307px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_18{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:290px;	width:321px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_19{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:371px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_20{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:274px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_21{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:355px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_22{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:323px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_23{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:484px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_24{	border-style:none;	z-index:2;	position: absolute;	left:497px;	top:468px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts1" type="text/css" >

@font-face {
	font-family: JLJMLF-AdvP4DF60E1;
	src: url("1/fonts/JLJMLF-AdvP4DF60E.woff") format("woff");
}

@font-face {
	font-family: JLJMLE-AdvP4DF6141;
	src: url("1/fonts/JLJMLE-AdvP4DF614.woff") format("woff");
}

@font-face {
	font-family: JLJMOI-AdvP4DF6121;
	src: url("1/fonts/JLJMOI-AdvP4DF612.woff") format("woff");
}

@font-face {
	font-family: JLJMNH-AdvP4C4E511;
	src: url("1/fonts/JLJMNH-AdvP4C4E51.woff") format("woff");
}

@font-face {
	font-family: JLJMNG-AdvP4DF60F1;
	src: url("1/fonts/JLJMNG-AdvP4DF60F.woff") format("woff");
}

@font-face {
	font-family: JLJMMG-AdvP4C4E741;
	src: url("1/fonts/JLJMMG-AdvP4C4E74.woff") format("woff");
}

</style>
<div id="t1_1" class="t s1_1">Expert’s comments:</div>
<div id="t2_1" class="t s2_1">Metformin, a first-line antidiabetic drug belonging to the bigua-</div>
<div id="t3_1" class="t s2_1">nide family, has been associated with a decreased risk of</div>
<div id="t4_1" class="t s2_1">subsequent cancers and an improved cancer-related outcome</div>
<div id="t5_1" class="t s3_1">[1]</div>
<div id="t6_1" class="t s2_1">. In a meta-analysis of 20 studies including</div>
<div id="t7_1" class="t s4_1">&gt;</div>
<div id="t8_1" class="t s2_1">13 000 cancer</div>
<div id="t9_1" class="t s2_1">patients with type 2 diabetes, metformin use increased overall</div>
<div id="ta_1" class="t s2_1">survival by 34% and cancer-specific survival by 38% for all</div>
<div id="tb_1" class="t s2_1">patients with cancer compared with nonmetformin use</div>
<div id="tc_1" class="t s3_1">[2]</div>
<div id="td_1" class="t s2_1">.</div>
<div id="te_1" class="t v1_1 s2_1">In patients with PCa treated with external-beam</div>
<div id="tf_1" class="t v1_1 s2_1">radiation therapy, metformin use was associated with</div>
<div id="tg_1" class="t v1_1 s2_1">improvement in all outcomes compared with the diabetic</div>
<div id="th_1" class="t v1_1 s2_1">nonmetformin group. In men experiencing biochemical</div>
<div id="ti_1" class="t v1_1 s2_1">failure, metformin use was also independently correlated</div>
<div id="tj_1" class="t v1_1 s2_1">with a decrease in the development of castration-resistant</div>
<div id="tk_1" class="t v1_1 s2_1">PCa (CRPC)</div>
<div id="tl_1" class="t v1_1 s3_1">[3]</div>
<div id="tm_1" class="t v1_1 s2_1">. In nondiabetic patients with chemotherapy-</div>
<div id="tn_1" class="t v1_1 s2_1">naive CRPC, metformin use led to disease stabilization and</div>
<div id="to_1" class="t v1_1 s2_1">prolongation of prostate-specific antigen doubling time in</div>
<div id="tp_1" class="t v1_1 s2_1">some patients</div>
<div id="tq_1" class="t v1_1 s3_1">[4]</div>
<div id="tr_1" class="t v1_1 s2_1">.</div>
<div id="ts_1" class="t v1_1 s2_1">The antineoplastic activity of metformin has been</div>
<div id="tt_1" class="t v1_1 s2_1">related to reduced hyperinsulinemia and glycemic levels.</div>
<div id="tu_1" class="t v1_1 s2_1">In addition, metformin selectively blocks the growth of</div>
<div id="tv_1" class="t v1_1 s2_1">cancer stem cells and inhibits the metabolic stress response</div>
<div id="tw_1" class="t v1_1 s2_1">that may stimulate the inflammatory pathway associated</div>
<div id="tx_1" class="t v1_1 s2_1">with a number of cancers. Because metformin is not</div>
<div id="ty_1" class="t v1_1 s2_1">believed to influence the transformation of benign cells to</div>
<div id="tz_1" class="t v1_1 s2_1">malignant cells but rather to modulate cellular energy,</div>
<div id="t10_1" class="t v1_1 s2_1">metformin may have a greater impact on cancer survival</div>
<div id="t11_1" class="t v1_1 s2_1">than on incidence. Metformin may also have other benefits</div>
<div id="t12_1" class="t v1_1 s2_1">for nondiabetic patients who require androgen deprivation</div>
<div id="t13_1" class="t v1_1 s2_1">therapy (ADT) through its insulin-sensitizing effects be-</div>
<div id="t14_1" class="t v1_1 s2_1">cause ADT can be associated with insulin resistance and</div>
<div id="t15_1" class="t v1_1 s2_1">metabolic syndrome.</div>
<div id="t16_1" class="t v1_1 s2_1">Because metformin is inexpensive, with only minor side</div>
<div id="t17_1" class="t v1_1 s2_1">effects in men with and without diabetes, and because PCa is</div>
<div id="t18_1" class="t v1_1 s2_1">a slow-growing disease, this drug could play a role in</div>
<div id="t19_1" class="t v1_1 s2_1">secondary prevention strategies</div>
<div id="t1a_1" class="t v1_1 s3_1">[5]</div>
<div id="t1b_1" class="t v1_1 s2_1">. Further studies are</div>
<div id="t1c_1" class="t v1_1 s2_1">necessary to show which PCa patients may benefit from this</div>
<div id="t1d_1" class="t v1_1 s2_1">therapy.</div>
<div id="t1e_1" class="t s5_1">Conﬂicts of interest:</div>
<div id="t1f_1" class="t s6_1">The author has nothing to disclose.</div>
<div id="t1g_1" class="t v1_1 s1_1">References</div>
<div id="t1h_1" class="t s7_1">[1]</div>
<div id="t1i_1" class="t s8_1">La Vecchia C, Bosetti C. Metformin: are potential bene±ts on cancer</div>
<div id="t1j_1" class="t s8_1">risk extended to cancer survival? Oncologist 2013;18:1245–7.</div>
<div id="t1k_1" class="t s7_1">[2]</div>
<div id="t1l_1" class="t s8_1">Yin M, Zhou J, Gorak EJ, et al. Metformin is associated with survival</div>
<div id="t1m_1" class="t s8_1">bene±t in cancer patients with concurrent type 2 diabetes: a system-</div>
<div id="t1n_1" class="t s8_1">atic review and meta-analysis. Oncologist 2013;18:1248–55.</div>
<div id="t1o_1" class="t s7_1">[3]</div>
<div id="t1p_1" class="t s8_1">Spratt DE, Zhang C, Zumsteg ZS, et al. Metformin and prostate</div>
<div id="t1q_1" class="t s8_1">cancer: reduced development of castration-resistant disease and</div>
<div id="t1r_1" class="t s8_1">prostate cancer mortality. Eur Urol 2013;63:709–16.</div>
<div id="t1s_1" class="t s7_1">[4] Rothermundt C, Hayoz S, Templeton AJ, et al. Metformin in chemo-</div>
<div id="t1t_1" class="t s7_1">therapy-naive castration-resistant prostate cancer: a multicenter</div>
<div id="t1u_1" class="t s7_1">phase 2 trial (SAKK 08/09). Eur Urol. In press.</div>
<div id="t1v_1" class="t s8_1"><a href="http://dx.doi.org/" target="_blank">http://dx.doi.org/</a></div>
<div id="t1w_1" class="t s8_1">10.1016/j.eururo.2013.12.057</div>
<div id="t1x_1" class="t s7_1">[5]</div>
<div id="t1y_1" class="t s8_1">Penney KL, Stampfer MJ. The time is ripe for a randomized trial of</div>
<div id="t1z_1" class="t s8_1">metformin in clinically localized prostate cancer. J Clin Oncol</div>
<div id="t20_1" class="t s8_1">2013;31:3054–5.</div>
<div id="t21_1" class="t s6_1">Dorothea Weckermann</div>
<div id="t22_1" class="t s8_1">*</div>
<div id="t23_1" class="t s9_1">Department of Urology, Klinikum Augsburg, Augsburg, Germany</div>
<div id="t24_1" class="t s6_1">*Department of Urology, Klinikum Augsburg, Stenglinstraße 2,</div>
<div id="t25_1" class="t s6_1">Augsburg, Bavaria 86156, Germany.</div>
<div id="t26_1" class="t s6_1">E-mail address:</div>
<div id="t27_1" class="t s8_1">dorothea.weckermann@klinikum-augsburg.de</div>
<div id="t28_1" class="t s6_1">.</div>
<div id="t29_1" class="t s8_1"><a href="http://dx.doi.org/10.1016/j.eururo.2014.03.037" target="_blank">http://dx.doi.org/10.1016/j.eururo.2014.03.037</a></div>
<div id="t2a_1" class="t v1_1 s1_1">Re: Increased Risk of Non-fatal Myocardial Infarction</div>
<div id="t2b_1" class="t v1_1 s1_1">Following Testosterone Therapy Prescription in Men</div>
<div id="t2c_1" class="t v1_1 s2_1">Finkle WD, Greenland S, Ridgeway GK, et al.</div>
<div id="t2d_1" class="t s2_1">PLoS One 2014;9:e85805</div>
<div id="t2e_1" class="t s1_1">Experts’ summary:</div>
<div id="t2f_1" class="t s2_1">Finkle and colleagues recently performed a secondary data</div>
<div id="t2g_1" class="t s2_1">analysis to investigate potential associations between testos-</div>
<div id="t2h_1" class="t s2_1">terone supplementation therapy (TST) and cardiovascular</div>
<div id="t2i_1" class="t s2_1">events. The authors used a large commercial database that</div>
<div id="t2j_1" class="t s2_1">covered claims from 2006 to 2010 and compared two cohorts</div>
<div id="t2k_1" class="t s2_1">of men: those who filled new prescriptions for TST and those</div>
<div id="t2l_1" class="t s2_1">who filled a new prescription for phosphodiesterase type 5</div>
<div id="t2m_1" class="t s2_1">inhibitors (PDE5-Is). The investigators then evaluated the rates</div>
<div id="t2n_1" class="t s2_1">of myocardial infarction (MI), as determined by International</div>
<div id="t2o_1" class="t s2_1">Classification of Diseases, 9th revision, codes, before and within</div>
<div id="t2p_1" class="t s2_1">3 mo after filling the first prescription in these groups.</div>
<div id="t2q_1" class="t v1_1 s2_1">The authors identified 55 593 men who filled a prescrip-</div>
<div id="t2r_1" class="t v1_1 s2_1">tion for TST and 167 279 men who filled a prescription for a</div>
<div id="t2s_1" class="t v1_1 s2_1">PDE5-I. Rates of MI increased in the 3 mo after filling a</div>
<div id="t2t_1" class="t v1_1 s2_1">TST prescription (from 3.48 per 1000 person-years before to</div>
<div id="t2u_1" class="t v1_1 s2_1">4.75 per 1000 person-years after; rate ratio: 1.36; 95%</div>
<div id="t2v_1" class="t v1_1 s2_1">confidence interval [CI], 1.03–1.81). The increase was more</div>
<div id="t2w_1" class="t v1_1 s2_1">pronounced in the subset of men</div>
<div id="t2x_1" class="t v1_1 s10_1">±</div>
<div id="t2y_1" class="t v1_1 s2_1">65 yr of age (5.27 per 1000</div>
<div id="t2z_1" class="t v1_1 s2_1">person-years before to 11.52 person-years after; rate ratio:</div>
<div id="t30_1" class="t v1_1 s2_1">2.19; 95% CI, 1.27–3.77). There was no corresponding</div>
<div id="t31_1" class="t v1_1 s2_1">increase in MI rate in men who filled a PDE5-I prescription</div>
<div id="t32_1" class="t v1_1 s2_1">(3.48 per 1000 person-years before to 3.75 per 1000 person-</div>
<div id="t33_1" class="t v1_1 s2_1">years after; rate ratio: 1.08; 95% CI, 0.93–1.24).</div>
<div id="t34_1" class="t s1_1">Experts’ comments:</div>
<div id="t35_1" class="t s2_1">The work by Finkle and colleagues is a secondary data analysis</div>
<div id="t36_1" class="t s2_1">of a large Claims and Encounters Database aimed at deter-</div>
<div id="t37_1" class="t s2_1">mining whether TST use was associated with cardiovascular</div>
<div id="t38_1" class="t s2_1">events. The findings are similar to those from a retrospective</div>
<div id="t39_1" class="t s2_1">cohort analysis of veterans with advanced cardiovascular</div>
<div id="t3a_1" class="t s2_1">disease</div>
<div id="t3b_1" class="t s3_1">[1]</div>
<div id="t3c_1" class="t s2_1">and the Testosterone in Older Men (TOM) trial</div>
<div id="t3d_1" class="t s3_1">[2]</div>
<div id="t3e_1" class="t s2_1">.</div>
<div id="t3f_1" class="t v1_1 s2_1">Although these three studies have potentially concerning</div>
<div id="t3g_1" class="t v1_1 s2_1">findings, they also exhibit methodological flaws that limit the</div>
<div id="t3h_1" class="t v1_1 s2_1">credibility of their results. For example, in the study by Vigen</div>
<div id="t3i_1" class="t v1_1 s2_1">et al.</div>
<div id="t3j_1" class="t v1_1 s3_1">[1]</div>
<div id="t3k_1" class="t v1_1 s2_1">, hypogonadal veterans who previously had an MI or</div>
<div id="t3l_1" class="t v1_1 s2_1">strokeand later receivedTST were excluded rather then being</div>
<div id="t3m_1" class="t v1_1 s2_1">assigned to the no-testosterone arm for analysis. Further-</div>
<div id="t3n_1" class="t v1_1 s2_1">more, the authors’ conclusions of there being increased risks</div>
<div id="t3o_1" class="t v1_1 s2_1">of MI or stroke associated with TST were based on Kaplan-</div>
<div id="t3p_1" class="t v1_1 s2_1">Meier estimates, not the absolute rates of MI or stroke. In the</div>
<div id="t3q_1" class="t v1_1 s2_1">TOM study</div>
<div id="t3r_1" class="t v1_1 s3_1">[2]</div>
<div id="t3s_1" class="t v1_1 s2_1">, the authors recorded as cardiac events</div>
<div id="t3t_1" class="t v1_1 s2_1">findings that are known side effects of testosterone such as</div>
<div id="t3u_1" class="t v1_1 s2_1">hypertension and lower extremity edema.</div>
<div id="t3v_1" class="t s11_1">EUROPEAN UROLOGY 66 (2014) 173–178</div>
<div id="t3w_1" class="t s12_1">175</div>

<form>
<input type="button"  tabindex="24"  id="form1_1" name="85 0 R"  pdfFieldName="85 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="2"  id="form1_2" name="63 0 R"  pdfFieldName="63 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="3"  id="form1_3" name="64 0 R"  pdfFieldName="64 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="5"  id="form1_4" name="66 0 R"  pdfFieldName="66 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="1"  id="form1_5" name="62 0 R"  pdfFieldName="62 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="21"  id="form1_6" name="82 0 R"  pdfFieldName="82 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="4"  id="form1_7" name="65 0 R"  pdfFieldName="65 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="23"  id="form1_8" name="84 0 R"  pdfFieldName="84 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="22"  id="form1_9" name="83 0 R"  pdfFieldName="83 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="18"  id="form1_10" name="79 0 R"  pdfFieldName="79 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025" />
<input type="button"  tabindex="14"  id="form1_11" name="75 0 R"  pdfFieldName="75 0 R" onclick="window.open('http://dx.doi.org/10.1016/j.eururo.2013.12.057','_blank');" style="cursor:pointer;" title="http://dx.doi.org/10.1016/j.eururo.2013.12.057" />
<input type="button"  tabindex="15"  id="form1_12" name="76 0 R"  pdfFieldName="76 0 R" onclick="window.open('http://dx.doi.org/10.1016/j.eururo.2013.12.057','_blank');" style="cursor:pointer;" title="http://dx.doi.org/10.1016/j.eururo.2013.12.057" />
<input type="button"  tabindex="19"  id="form1_13" name="80 0 R"  pdfFieldName="80 0 R" onclick="window.location.href='mailto:dorothea.weckermann@klinikum-augsburg.de';" style="cursor:pointer;" title="mailto:dorothea.weckermann@klinikum-augsburg.de" />
<input type="button"  tabindex="20"  id="form1_14" name="81 0 R"  pdfFieldName="81 0 R" onclick="window.open('http://dx.doi.org/10.1016/j.eururo.2014.03.037','_blank');" style="cursor:pointer;" title="http://dx.doi.org/10.1016/j.eururo.2014.03.037" />
<input type="button"  tabindex="13"  id="form1_15" name="74 0 R"  pdfFieldName="74 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015" />
<input type="button"  tabindex="8"  id="form1_16" name="69 0 R"  pdfFieldName="69 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010" />
<input type="button"  tabindex="10"  id="form1_17" name="71 0 R"  pdfFieldName="71 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010" />
<input type="button"  tabindex="7"  id="form1_18" name="68 0 R"  pdfFieldName="68 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0005','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0005" />
<input type="button"  tabindex="12"  id="form1_19" name="73 0 R"  pdfFieldName="73 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015" />
<input type="button"  tabindex="6"  id="form1_20" name="67 0 R"  pdfFieldName="67 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0005','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0005" />
<input type="button"  tabindex="11"  id="form1_21" name="72 0 R"  pdfFieldName="72 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0015" />
<input type="button"  tabindex="9"  id="form1_22" name="70 0 R"  pdfFieldName="70 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0010" />
<input type="button"  tabindex="17"  id="form1_23" name="78 0 R"  pdfFieldName="78 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025" />
<input type="button"  tabindex="16"  id="form1_24" name="77 0 R"  pdfFieldName="77 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00290-5/sbref0025" />

</form>
<div id="pg1Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg1"><object width="909" height="1212" data="1/1.svg" type="image/svg+xml" id="pdf1" style="width:909px; height:1212px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 141;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_1");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
